Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Amortizatization of Intangibles: 2014-2025

Historic Amortizatization of Intangibles for KalVista Pharmaceuticals (KALV) over the last 3 years, with Apr 2025 value amounting to $3,000.

  • KalVista Pharmaceuticals' Amortizatization of Intangibles fell 25.00% to $3,000 in Q2 2025 from the same period last year, while for Apr 2025 it was $17,000, marking a year-over-year decrease of 81.52%. This contributed to the annual value of $14,000 for FY2025, which is 84.78% down from last year.
  • According to the latest figures from Q2 2025, KalVista Pharmaceuticals' Amortizatization of Intangibles is $3,000, which was down 40.00% from $5,000 recorded in Q4 2024.
  • Over the past 5 years, KalVista Pharmaceuticals' Amortizatization of Intangibles peaked at $62,000 during Q3 2023, and registered a low of $3,000 during Q2 2025.
  • In the last 3 years, KalVista Pharmaceuticals' Amortizatization of Intangibles had a median value of $5,000 in 2024 and averaged $15,000.
  • Data for KalVista Pharmaceuticals' Amortizatization of Intangibles shows a maximum YoY tumbled of 91.94% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows KalVista Pharmaceuticals' Amortizatization of Intangibles stood at $21,000 in 2023, then slumped by 76.19% to $5,000 in 2024, then decreased by 25.00% to $3,000 in 2025.
  • Its last three reported values are $3,000 in Q2 2025, $5,000 for Q4 2024, and $5,000 during Q3 2024.